Member Info for Lebus

Tommy - perfectly reasonable to question the CEO’s performance I would have thought. After 20 years at the helm we are hardly reaping the benefits of his leadership

Great effort reporting back, and really appreciated

Tommy - with respect, I would suggest that it is private and Institutional investors who have kept this particular show on the road over the past two decades

Doc - whether or not Mr Costas attends the agm - who cares? Those who can will, and those who can’t won’t. The issue is, why can’t he be allowed to complain about a business that has sustained such a significant depreciation in value? He raises perfectly legitimate questions in my view, and the relentless assault on his every post is baffling to me. A balanced discussion and tolerance for the views of others - surely that’s how we form if need be adjust our opinions isn’t it?

Ok so how does your personal opinion of another poster impact on his right to express a view - and a view that seems to support the argument that this business is underperforming?

Sorry but I struggle to understand why some contributors to this chat forum react in such an offensive way to MrCosts posts. This business is nigh on 20 years old. No product in the marketplace, and not remotely close to having a licensed product. Synairgen is still entirely dependant on investors paying for operational costs and very substantial salaries. Last cash raise at 175p. Share price now around 8p. So, do investors not have a right to grumble,complain,criticise? Of course we do.This business is under forming on an epic scale. So why throw barbs at those who speak the self evident?

Spot on Spacman. The fat cats are heads down in the trough whilst their investors burn. Two decades on and no product in the marketplace or even remotelessly close. Still totally reliant on Institutional and private investors funding their very substantial salaries and operating costs. Still, “we know it works”, and they are of course “working at haste”.

Who takes responsibility for the phase 3 fiasco? Will those responsible for designing the trial be involved in any future trial design? We don’t know is the answer.

We all invested because we believed in the science. The science is never enough. This business is stale. We need new leadership with fresh energy, focus, and commercial nous. RM has taken enough of my hard earned

Sharedealer _ with respect, nigh on 20 years is long haul enough for some of us. Still no marketable product, still loss making and a relentlessly depreciating sp. the business is stale and we need a new dynamic CEO. we also need top drawer business savvy communicators

It is beyond my undersranding how RM is still CEO. He has had nearly two decades to deliver and failed miserably and at a huge cost to investors. He should fall on his sword.

And the sell off starts to gather pace. Investors who have finally given up and baling out out at a loss. What a shambles of a business. Twenty years of a fat cat salary and the silence is deafening

“The decamping keeps falling at pace” No my friend, the share price keeps falling at pace. Fact

Post Sprinter failure there should have been a clear out. New dynamic CEO and freshen up the board with commercial expertise. Nigh on 20 years is enough. The folk running this business are incapable of getting this single product over the line

In a world of finite resources RM could have saved a lot of ink by simply saying, “Happy New Year to all our investors. I can confirm that 2023 will be business as usual. Oh, and soz about the phase 3 failure. Never mind eh”

It got replaced by “working at haste”

Are you not used to it yet? Only strange when the sp rises over recent months

Circa £2.00 to 15p in under 12 months. So, nothing to be nervous about dunk? You must know a lot more than the rest us inexperienced investors

Fair point, although I now need 1000% rise to break even. I know the risks Doc - having an occasional moan when it all goes belly up just makes me feel a bit better. Have a nice weekend everyone

And sp now 16.49p. Jeez. Those of us who financed the sprinter trial say anything negative and we are trolls or derampers. No, just disillusioned and angry at the inertia. Does anyone doubt that a major pharma would have taken nearly 20 years toget this product over the line? They tell us “we know it works”. Cmon, bat it over to people who know how to get a drug into the marketplace

17.5p close. Joint venture, buyout, Strive, blah blah blah. Oops soz, forgot, gotta be positive and any doubts about this business and the fat cats coining it in for nearly two decades strictly not allowed. I’ll get my coat

SP closed today at 17.50. Talk of 35p a little premature maybe?